2018 AVBCC Summit Agenda

AVBCC

October 29-31, 2018 | New York Athletic Club, New York, NY

Monday, October 29

5:00 pm – 8:00 pm
Meet and Greet Networking Reception Honoring the Charitable Foundation for National Cancer Research Swim Across America
Co-Chairs
  • Burt Zweigenhaft, Managing Partner, Upstream Partners; Co-Founder, AVBCC
  • Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC
  • William McGivney, Principal, McGivney Global Advisors
  • Jayson Slotnik, JD, MPH, Managing Partner, Health Policy Strategies
Co-Chair Segment Advisors
  • Washington Legislation and Public Policy
    Jayson Slotnik, JD, MPH, Managing Partner, Health Policy Strategies
    Marc Samuels, JD, MPH, Managing Partner, ADVI Health LLC
  • Cancer Centers of Excellence
    Maurie Markman, MD, CMO, Cancer Treatment Centers of America
    Robert Carlson, MD, CEO, National Comprehensive Cancer Network
  • Community-Based Cancer Care
    Debra Pratt, MD, MPH, MBA, Texas Oncology
    Christian Downs, JD, MHA, CEO, Association of Community Cancer Centers
  • Value-Based Performance and Standards
    William McGivney, Partner, McGivney Global Advisors
    Mark Fendrick, MD, University of Michigan Value-Based Insurance Design
  • Real-World Performance and Value-Based Care
    Jennifer Hinkel, Partner, McGivney Global Advisors
    Brent Clough, CEO, Trio Health
  • Practice Management
    Jeffrey Scott, MD, President and CMO, Integra Connect
    Brenton Fargnoli, MD, Product Marketing & Strategy, Flatiron Health
  • Personalized Medicine and Genomics
    Louis Jacques, MD, ADVI Health LLC
    Tom Civik, Chief Commercial Officer, Foundation Medicine
  • Oncology Supply Chain and Specialty Pharmacy
    Darin Rubin, CEO, The Dedham Group
    Kelly Ratliff, President, US BioServices Division, AmerisourceBergen
  • Patient-Centered Cancer Care
    Lillie Shockney, RN, BS, MAS, Program Director and Co-Founder, Academy of Oncology Nurse & Patient Navigators
    Brenda Nevidjon, RN, MSN, CEO, Oncology Nursing Society
  • Telemedicine and Cancer Care
    Joel Stein, CEO, AdhereTech
  • Patient Voice and Advocacy
    Robert Goldberg, PhD, VP, Center for Medicine in the Public Interest
    Amy Niles, VP, Patient Access Network Foundation

Tuesday, October 30

6:30 am – 8:00 am Mini-Roundtables
6:30 am – 7:45 am Breakfast – Ballroom Exhibit Hall
7:45 am – 8:00 am Opening Remarks
Burt Zweigenhaft, Co-Chair, AVBCC
8:00 am – 8:30 am Keynote
Scott Gottlieb, MD, FDA Commissioner
8:30 am – 9:00 am Tomorrow’s Cancer Care: A Government Policy Perspective
Moderator: Jayson Slotnik, JD, MPH, Managing Partner, Health Policy Strategies
9:00 am – 9:30 am Tomorrow’s Cancer Care: An Insurance Payer’s Perspective
Moderator: Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC
Faculty: Brian Loy, MD, Humana
9:30 am – 10:00 am Tomorrow’s Cancer Care: A Community-Based Perspective
Faculty:
  • Barry Brooks, MD, US Oncology
  • Christian Downs, JD, MHA, CEO, Association of Community Cancer Centers
  • Debra Pratt, MD, MPH, MBA, Texas Oncology
10:00 am – 10:30 am Tomorrow’s Cancer Care: A Center of Excellence Perspective
Moderator: Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC
Faculty:
  • Maurie Markman, MD, CMO, Cancer Treatment Centers of America
  • Robert Carlson, MD, CEO, National Comprehensive Cancer Network
10:30 am – 11:00 am Tomorrow’s Cancer Care: An Employer’s Perspective
Moderator: Jonathan Fassberg, CEO, Solebury Trout
Faculty:
  • John L. Donnelly, Head, Human Resources, JPMorgan Chase & Co
  • Vice President, PNC Bank (TBD)
11:00 am – 11:30 am Tomorrow’s Cancer Care: The Patient Voice and Advocate Perspective
Moderator: Peter L. Saltonstall, President & CEO, National Organization for Rare Diseases
Faculty:
  • Dan Klein, President, Patient Access Network
  • Patricia Goldsmith, CEO, CancerCare
  • Clorinda Walley, CEO, Chronic Disease Fund
11:30 am – 12:00 pm Tomorrow’s Cancer Care: A Pharma Perspective
Moderator: Jonathan Fassberg, CEO, Solebury Trout
Faculty:
  • Mikael Dolstein, MD, President, World Research and Development, Pfizer
  • Axel Hoos, MD, SVP, Head, Oncology R&D, GlaxoSmithKline
12:00 pm – 12:45 pm Lunch – Ballroom Exhibit Hall
1:45 pm – 2:15 pm Keynote: Cancer Care into the Future
Clifford Hudis, MD, FACP, CEO, American Society of Clinical Oncology
1:45 pm – 2:15 pm Understanding Value Issues: Real-World Applications and Implications
Moderator: William McGivney, Partner, McGivney Global Advisors
Faculty:
  • Richard Schilsky, MD, FACP, American Society of Clinical Oncology
  • Steven Pearson, MD, MSc, President, Institute for Clinical and Economic Review
  • Peter Bach, MD, Memorial Sloan Kettering Cancer Center
2:30 pm – 3:15 pm
BREAKOUT – Session 1: Pharmaceutical Industry Ecosystem Overview
Moderator: Jayson Slotnik, JD, MPH, Managing Partner, Health Policy Strategies
Faculty: Michelle Drozd, Deputy VP, Policy and Research, Pharmaceutical Research and Manufacturers of America
BREAKOUT – Session 2: Performance Optimization Strategies in Cancer Care
Moderator: Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC
Faculty: Diana Verilli, VP, US Oncology McKesson
BREAKOUT – Session 3: From K Street to Wall Street: A Look at Cancer Policy Influence on Markets
Moderator: Ipsita Smolinski, CEO, Capitol Street
Faculty: Lisa Gill, JPMorgan Chase & Co
3:15 pm – 4:00 pm
BREAKOUT – Session 4: Oncology Medical Home and Update on the CMMI Model
Faculty: Anand Shah, MD, MPH, CMO, Center for Medicare & Medicaid Innovation, Centers for Medicare & Medicaid Services
BREAKOUT – Session 5: Innovative Oncology Contracting Between Payers and Providers
Moderator: Mark Fendrick, MD, University of Michigan Value-Based Insurance Design
Faculty: Jim Kenney, VP, Harvard Pilgrim Health; President, Academy of Managed Care Pharmacy
BREAKOUT – Session 6: Latest Trends on Off-Label Promotion: A Legal View
4:00 pm – 4:45 pm
BREAKOUT – Session 7: Cancer Treatment Innovation Pathways, Forums, and Clinical Tools
Moderator: Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC
Faculty:
  • Robert J. Green, MD, SVP, Clinical Oncology, Flatiron Health
  • Anand Shah, MD, MPH, CMO, Center for Medicare & Medicaid Innovation, Centers for Medicare & Medicaid Services
BREAKOUT – Session 8: Employers and Managing the Economic Reality of Cancer Spending
Moderator: Randy Rosenberg, PhD, RPh, Partner, National Institute of Collaborative Healthcare
BREAKOUT – Session 9: Biosimilars and Impact on Cancer Care
Moderator: Bob Charles, MBA, CEO, The Generisys Company
Faculty:
  • Mark Vineis, Sandoz
  • Robert Shelley, Pfizer
4:45 pm – 5:00 pm Break
5:00 pm – 5:45 pm Keynote – Cancer Drug Trend Report
Moderator: Burt Zweigenhaft, Co-Chair, AVBCC
Faculty: Doug Long, VP, Industry Relations, IQViA
5:45 pm – 7:45 pm Evening Network Reception

Wednesday, October 31

7:00 am – 8:00 am Mini-Roundtables
7:00 am – 8:00 am Breakfast Presentation
Oncology Drug Pipeline Overview, Next 3 Years

Moderator: Burt Zweigenhaft, Co-Chair, AVBCC
Faculty:
  • Ray Trancredi, RPh, MBA, CSP, Divisional VP, Specialty Pharmacy Development & Brand Rx/Vaccine Purchasing, Walgreens
  • Cheryl Allen, PharmD, Diplomat Specialty Pharmacy
8:00 am – 8:15 am Opening Remarks
Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC
8:00 am – 9:00 am
Keynote
Rowdy Gaines, Three-Time Olympic Gold Medalist and NBC Sports Commentator
Discussion with former Olympic cancer survivors
Distinguished Researchers Panel
Moderator: Neil Canavan, Author, The Cure Within
Panelists:
  • Jedd Wolchok, MD, Memorial Sloan Kettering Cancer Center
  • Luis Diaz, MD, Memorial Sloan Kettering Cancer Center
  • Axel Hoos, MD, President, Oncology, GlaxoSmithKline
9:00 am – 10:30 am Cancer Care Perspectives from Capitol Hill and in Emerging Public Policy
Moderator: Marc Samuels, JD, MPH, Managing Partner, ADVI Health LLC
Faculty:
  • Kavita Patel, Fellow, Brookings Institution
  • Liz Fowler, VP, Global Health Policy, Johnson & Johnson
10:45 am – 11:15 am Genomics and Personalized Medicine
Moderator: Louis Jacques, MD, ADVI Health LLC
Faculty:
  • Selin Kurnaz, PhD, CEO, Massive Bio
  • Vince Miller, MD, Foundation Medicine
  • Edward Abramson, CEO, Personalized Medicine Coalition
11:15 am – 11:45 am Economic Overview of Cancer Treatment Cost and Trends
Moderator: Burt Zweigenhaft, Co-Chair, AVBCC
Faculty: Bruce S. Pyenson, FSA, MAAA, Principal and Consulting Actuary, Milliman
11:45 am – 12:30 pm Future Trends and Observations in Cancer Care Ecosystem
Moderator: Burt Zweigenhaft, Co-Chair, AVBCC
Faculty: Dan Mendelson, President, Avalere Health
12:30 pm – 1:30 pm Lunch Keynote
Greg Simon, President, Biden Cancer Initiatives
1:45 pm – 2:30 pm
BREAKOUT – Session 10: Pharmacy Benefit Managers and Cancer Care Initiatives
Moderator: Mike Ellis, CEO, Maxor National Pharmacy Services
  • CVS
  • OPTUM
  • ExpressScripts
BREAKOUT – Session 11: TeleHealth and Digital Medicine and Its Role in Cancer Care
Faculty: Proteus
BREAKOUT – Session 12: Wall Street and Investment in Cancer Care Ecosystems
Moderator: David Vorhoff, VP, Premier
Faculty: Richard Brown, SVP, PNC Bank
2:30 pm – 3:15 pm
BREAKOUT – Session 13: Strategies for Delivering on Pharmaceutical Value
Moderator: Darin Rubin, CEO, The Dedham Group
Faculty:
  • Danielle Ziernicki, PharmD, Janssen
  • Dina Smith, Bayer
  • Matt Otten, Pharmacyclics
BREAKOUT – Session 14: Big Data: “The New Oil”
Moderator: Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC
Faculty: Brad Hirsch, MD, Senior Medical Director, Flatiron Health
BREAKOUT – Session 15: Blockchain and Use Cases in Cancer Healthcare
Moderator: John Bass, Hashed Health
3:15 pm – 4:00 pm
BREAKOUT – Session 16: Standardized Measurements and Process for Navigating Cancer Care
Moderator: Lillie Shockney, RN, BS, MAS, Program Director and Co-Founder, Academy of Oncology Nurse & Patient Navigators
Faculty:
  • Tricia Strusowski, RN, MS
  • Danelle Johnston, MSN, RN, ONN-CG, OCN
BREAKOUT – Session 17: CAR-T Immuno-Oncology Session
Moderator: Michael Kolodziej, MD, VP and Chief Innovation Officer, ADVI Health LLC
Faculty:
  • Novartis
  • Bob Azelby, Chief Commercial Officer, Juno Therapeutics
  • Alfred Slanetz, PhD, CEO, Geneius Biotechnology
BREAKOUT – Session 18: Artificial Intelligence and Machine Learning Role in Cancer Care
Moderator: Morrie Ruffin, CEO, Adjuvant Partners
Faculty:
  • T. May Pini, MD, Premier
  • George Daneker, MD, Cancer Treatment Centers of America
4:00 pm – 4:45 pm
BREAKOUT – Session 19: Role of the Specialty Pharmacy in Cancer Care
Moderator: Sheila Arquette, PharmD, Executive Director, National Association of Specialty Pharmacy
Faculty:
  • Ray Bailey, Director of Pharmacy, Florida Cancer Specialists
  • Michael Agostino, CEO, Amber Specialty Pharmacy
  • Matt Farber, Walgreens
BREAKOUT – Session 20: Walking Barefoot in the Patient Role
Moderator: Robert Goldberg, PhD, VP, Center for Medicine in the Public Interest
Faculty:
  • Lillie Shockney, RN, BS, MAS, Program Director and Co-Founder, Academy of Oncology Nurse & Patient Navigators
  • Brenda Nevidjon, RN, MSN, CEO, Oncology Nursing Society
BREAKOUT – Session 21: Cancer Care Reimbursement Issues, Coding, and Trends
Moderator: Jayson Slotnik, JD, MPH, Managing Partner, Health Policy Strategies
Faculty: Joel Brill, MD, CEO, Predictive Health
5:00 pm – 5:30 pm Closing Remarks

*Agenda is subject to change.